Tower Research Capital (TRC)’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Tower Research Capital (TRC)’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-104	Closed	-$5	–	6338
2023 Q3	$5	Hold	104	–	–	﹤0.01%	5886
2023 Q2	$22	Hold	104	–	–	﹤0.01%	5922
2023 Q1	$0	Hold	104	–	–	﹤0.01%	6535
2022 Q4	$0	Hold	104	–	–	﹤0.01%	6611
2022 Q3	$0	Hold	104	–	–	﹤0.01%	6702
2022 Q2	$0	Hold	104	–	–	﹤0.01%	6749
2022 Q1	$0	Hold	104	–	–	﹤0.01%	6799
2021 Q4	$0	Hold	104	–	–	﹤0.01%	6753
2021 Q3	$0	Hold	104	–	–	﹤0.01%	6332
2021 Q2	$0	Buy	+104	New	+$470	﹤0.01%	5999

Other funds holding CANO.WS

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Tower Research Capital (TRC)'s CANO.WS Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2023, closing a stake of 104 shares — an estimated $5 sold.

Tower Research Capital (TRC) first reported a position in CANO.WS in Q2 2021 and held it in 10 quarters. The position peaked at $22 in Q2 2023. 2 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2023.

Tower Research Capital (TRC) reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 104 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2023, an estimated $5.
Tower Research Capital (TRC) first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 10 quarters.
Tower Research Capital (TRC)'s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $22 in Q2 2023.
2 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.